Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Why Clinicians Make Great MSLs
Summary
In this episode, Tom Caravela is joined by Dawn O'Reilly, who shares her journey into the MSL role and offers valuable insights for clinicians transitioning into this field. Dawn discusses why clinicians are well-suited for MSL positions and provides advice for those making the switch. She reflects on lessons learned, emphasizing the importance of patience and the skills necessary for new MSLs. The conversation also covers the unique challenges of navigating the MSL role during the pandemic and the shift to virtual work. Dawn concludes with her future aspirations and the significance of mentoring, encouraging listeners to pursue their goals.
Dawn O'Reilly, Ph.D., MMS, PA-C, Medical Science Liaison at Biodesix discusses why and how clinicians make great Medical Science Liaisons
Dawn shares…
👉 Tips and advice to transition to an MSL role
👉 What skills clinicians need to develop for industry roles
👉 The importance of networking in your career and job search
👉 What challenges you can expect as an MSL
👉 Why patience is so critical
Medical Science Liaison, MSL role transition, clinician to MSL, networking for MSLs, MSL career advice
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO